Snowball logo
logo
PHAR_logo

Pharming Group NV

€1.016-€0.012Β  (1.17%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
189.9205.6226.9297.1376.1366.3
COGS
20.1817.5633.535.445.549.45
Gross Profit
169.7188.1193.4261.8330.6316.8
Operating Expenses & Income
Operating Income
27.8418.23(20.38)(3.665)20.8812.53
Total Operating Expenses
156.7169.8213.8265.5309.8298
R&D Expenses
67.1852.5360.1475.97100.4112.7
Selling General & Admin Expenses
35.346.0280.6892.08110.823,538.9
Earnings from Continuing Operations
Interest Expense
(5.915853)(5.358)(5.964)(9.047076)(10.72)(1,657.7)
Interest Income
12.570.0853.6634.8582.1765.143
Income Tax Expense
6.760491.313(1.354156)3.34910.316.532347
Net Income
Net Income
1613.67(9.756588)(11.84)2.9672339.340841
Supplemental
EBIT
27.8418.23(20.38)3.07481223.5723.67
EBITDA
46.5632.61(10.2)13.6534.7835.65
In millions of EUR, except % and values per 1 share